<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00981422</url>
  </required_header>
  <id_info>
    <org_study_id>PARMABIOMARKERS001</org_study_id>
    <nct_id>NCT00981422</nct_id>
  </id_info>
  <brief_title>Search for Biomarkers in Human Glaucoma: Lymphocytes Alterations and Rate of Progression</brief_title>
  <official_title>Search for Biomarkers in Human Glaucoma: Possible Correlations Between Alterations in Peripheral Lymphocytes and Disease Severity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Parma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Parma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to evaluate the lymphocyte phenotype in primary open- angle
      glaucoma (POAG) patients compared to healthy subjects of the same age, in order to confirm
      the importance of immune responses in glaucoma and the possible correlation to the severity
      of the disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>compare the lymphocyte phenotype of POAG patients to healthy subjects of the same age</measure>
    <time_frame>the same day of bloodwithdrawal</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlate the immunophenotype of POAG patients to the severity of disease</measure>
    <time_frame>within 3 months after blood withdrawal</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Glaucoma, Open-Angle</condition>
  <arm_group>
    <arm_group_label>Glaucoma patients</arm_group_label>
    <description>POAG patients selected by an ophthalmologist from the Glaucoma Service, Ophthalmology Institute, University of Parma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>healthy subjects with negative history for (a) neurodegenerative diseases, (b) autoimmune diseases, (c) cancer, (d) viral infection, (e) diabetes, and (f) systemic inflammation</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic in Parma (University hospital of Parma)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of primary open-angle glaucoma

          -  age between 19 an 85 years old

        Exclusion Criteria:

          -  age less than 19 or more than 85 yrs

          -  positive history for (a) neurodegenerative diseases, (b) autoimmune diseases, (c)
             cancer, (d) viral infection and (e) diabetes, (f)systemic inflammation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano A Gandolfi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ophthalmology Institute, University of Parma, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda ospedaliera universitaria</name>
      <address>
        <city>Parma</city>
        <zip>43100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2009</study_first_submitted>
  <study_first_submitted_qc>September 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2009</study_first_posted>
  <last_update_submitted>September 21, 2009</last_update_submitted>
  <last_update_submitted_qc>September 21, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2009</last_update_posted>
  <responsible_party>
    <name_title>STEFANO GANDOLFI, Professor of Ophthalmology and Chairman</name_title>
    <organization>UNIVERSITY OF PARMA</organization>
  </responsible_party>
  <keyword>glaucoma</keyword>
  <keyword>immunology</keyword>
  <keyword>immunophenotype</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

